Mirror, Mirror 2024 is your opportunity to explore the impact of policy choices on health and well-being across 10 countries, including the U.S. Read the report here.

Prescription Drugs

Overview Resources

Rows of pills

Controlling Health Care Costs

Key Provisions of Drug Pricing Proposals

publication / Apr 26, 2021

prescription drug prices in the US

Controlling Health Care Costs

Paying for Prescription Drugs Around the World: Why Is the U.S. an Outlier?

Issue Briefs / Oct 05, 2017

Pharmacist and patient discussing prescription drugs

Controlling Health Care Costs

The Case for Drug-Pricing Reform — The Cost of Inaction

blog / May 26, 2021

Featured

Pills pouring out into a mans hand

Controlling Health Care Costs

Allowing Medicare to Negotiate Drug Prices

Explainer / May 05, 2021

Medicare recipient sorting prescriptions

Controlling Health Care Costs

Inflation Rebate Penalty for Drug Companies

Explainer / Jun 17, 2021

Woman and pharmacist speaking, both wearing masks

Controlling Health Care Costs

Medicare Part D Redesign

Explainer / May 05, 2021

Doris Hölzl, pharmacist, gives FFP2 masks to a customer in a pharmacy in Berlin-Wilmersdorf as part of the free distribution of FFP2 masks to risk groups.

Controlling Health Care Costs

External Reference Pricing: The Drug-Pricing Reform America Needs?

Issue Briefs / May 27, 2021

senior woman on phone looks at pill packets on table

Controlling Health Care Costs

How Federal Drug-Pricing Proposals Could Affect Medicaid

blog / Aug 19, 2021

blue pills in machine manufactured with white gloved hand in background

Controlling Health Care Costs

Reducing Medicaid Prescription Drug Costs While Maintaining Beneficiary Access: MACPAC Recommendations for Accelerated-Approval Drugs

blog / Aug 18, 2021

Search content about
Prescription Drugs

Administration’s New Budget and Drug Prices

Controlling Health Care Costs

Administration’s New Budget Proposals May Align with Bipartisan Congressional Action to Lower Drug Prices

Blog / Mar 15, 2019

Drug pricing debate and recent actions

Controlling Health Care Costs

The Drug Pricing Debate: Sizing Up Recent Actions and What May Come Next

Blog / Mar 07, 2019

Reference pricing for pharmaceuticals

Controlling Health Care Costs

Reference Pricing in Germany: Implications for U.S. Pharmaceutical Purchasing

Issue Briefs / Feb 04, 2019

Drug prices are on the rise

Controlling Health Care Costs

The FDA’s Drug Pricing Strategy: What’s New?

Blog / Jan 28, 2019

senior opens medications

Controlling Health Care Costs

Proposed Changes to Medicare Part D Would Benefit Drug Manufacturers More Than Beneficiaries

Blog / Jan 02, 2019

Medicare part B drug payment model

Controlling Health Care Costs

Old Lessons for the New Medicare Part B Drug Payment Model

Blog / Nov 26, 2018

Q&A Header

Controlling Health Care Costs

What’s Driving Prescription Drug Prices in the U.S.?

Journal Article / Nov 14, 2018

Opioid epidemic long road ahead

Achieving Universal Coverage

Medicaid Provisions in the SUPPORT Act: An Important Step Forward in the Opioid Epidemic, but the Road Ahead Is Long

Blog / Nov 13, 2018

midterm election voting booth

Achieving Universal Coverage

The Midterm Election Results Have Big Implications for Health Care

Blog / Nov 07, 2018

prescription pills

Controlling Health Care Costs

HHS Proposes to Link Medicare Part B Payment for Prescription Drugs to International Price

Blog / Oct 26, 2018

Progress on drug costs

Controlling Health Care Costs

Congress Is Making Quiet Progress on Drug Costs

Blog / Sep 21, 2018

Opioid legislation

Improving Health Care Quality

A Closer Look at the Senate’s Bipartisan Legislation Targeting the Opioid Epidemic

Blog / Sep 13, 2018

1 … 5 6 7 8 9 10 11 12 13 14